Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Nike versus Adidas: Which brand won the World Cup?
We sift through data from AdClarity, Meltwater, Sprout Social and MediaRadar to work out which brand had the best World Cup performance.
Ad Tech Briefing: Apple’s continued interest in ads
A subtle policy update shines a light on how Apple differs from Google.
Five things the World Cup taught marketers about creators
The World Cup has wrapped, which means it’s time for the obligatory marketing takeaways piece.